Correction: Targeting Brd4 for cancer therapy: inhibitors and degraders (MedChemComm (2018) 9 (1779–1802) DOI: 10.1039/C8MD00198G

Abstract

The authors regret that some chemical structures are not correct in their review article entitled ‘Targeting Brd4 for cancer therapy: inhibitors and degraders’. The corrected structures for compound 20 in Fig. 4, compounds 26–35 in Fig. 6, compounds 96–98 in Fig. 21 and compounds 102–104 in Fig. 23 are shown below. [Figure Presented]. The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.